Evidence map›Paper›PMID 34234232›Full record

ArticleScientific reports2021

Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples.

Haisheng Wu, Qiuyan Yu, Liping Ma, Lin Zhang, Yuliang Chen, Pi Guo, Peng Xu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Haisheng Wu *Department of Preventive Medicine, Shantou University Medical College, No. 22 Xinling Road, Shantou, 515041, China.
Qiuyan Yu *Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, University Town, Wenzhou, 325035, China.
Liping MaHengrui Pharmaceutical Co., Ltd., No. 7 Kunlun Mountain Road, Lianyungang Economic and Technological Development Zone, Lianyungang, Jiangsu, China.
Lin ZhangZhoukou Center for Disease Control and Prevention, No.10 Taihao Road East Section, Zhoukou, Henan, China.
Yuliang ChenDepartment of Preventive Medicine, Shantou University Medical College, No. 22 Xinling Road, Shantou, 515041, China.
Pi GuoDepartment of Preventive Medicine, Shantou University Medical College, No. 22 Xinling Road, Shantou, 515041, China. pguo@stu.edu.cn.
Peng XuNational Center for STD/AIDS Prevention and Control, Chinese Center for Disease Control and Prevention, No. 155 Changbai Road, Beijing, 102206, China. xupeng2007@163.com.
Shantou University Medical College · CNJiangsu Hengrui Medicine (China) · CNNational Center for AIDS/STD Control and Prevention,China CDC · CNShantou University · CNWenzhou Medical University · CNZhoukou City Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm

Indexed as

Models, TheoreticalSexual PartnersAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCohort StudiesCost-Benefit AnalysisFemaleHIV InfectionsHIV SeropositivityHumansMaleMarkov ChainsMiddle AgedPublic Health SurveillanceQuality-Adjusted Life YearsAnti-HIV Agents

Identifiers

PMID34234232
PMCPMC8263699
OpenAlexW3178903845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.